47 related articles for article (PubMed ID: 8888088)
1. Correction: Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.
Wu Y; Lu Z; Liang P; Zhu H; Qi H; Zhang H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5329. PubMed ID: 38334826
[No Abstract] [Full Text] [Related]
2. Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach.
Maguigan KL; Al-Shaer MH; Peloquin CA
Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680734
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System.
Por ED; Akers KS; Chung KK; Livezey JR; Selig DJ
J Clin Pharmacol; 2021 Sep; 61(9):1182-1194. PubMed ID: 33811332
[TBL] [Abstract][Full Text] [Related]
4. Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant
Kim TH; Tao X; Moya B; Jiao Y; Basso KB; Zhou J; Lang Y; Sutaria DS; Zavascki AP; Barth AL; Reeve SM; Schweizer HP; Deveson Lucas D; Boyce JD; Bonomo RA; Lee RE; Shin BS; Louie A; Drusano GL; Bulitta JB
mBio; 2020 Feb; 11(1):. PubMed ID: 32047131
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.
Cies JJ; LaCoursiere RJ; Moore WS; Chopra A
J Pediatr Pharmacol Ther; 2017; 22(6):467-470. PubMed ID: 29290748
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.
Couffignal C; Pajot O; Laouénan C; Burdet C; Foucrier A; Wolff M; Armand-Lefevre L; Mentré F; Massias L
Br J Clin Pharmacol; 2014 Nov; 78(5):1022-34. PubMed ID: 24903189
[TBL] [Abstract][Full Text] [Related]
7. Management of antimicrobial use in the intensive care unit.
Álvarez-Lerma F; Grau S
Drugs; 2012 Mar; 72(4):447-70. PubMed ID: 22303918
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira J; Póvoa P
Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
[TBL] [Abstract][Full Text] [Related]
9. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.
Zilberberg MD; Chen J; Mody SH; Ramsey AM; Shorr AF
BMC Pulm Med; 2010 Aug; 10():45. PubMed ID: 20796312
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
Pea F; Viale P; Furlanut M
Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.
McKinnon PS; Davis SL
Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):271-88. PubMed ID: 15015030
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of the carbapenems: clinical implications.
Mouton JW; Touzw DJ; Horrevorts AM; Vinks AA
Clin Pharmacokinet; 2000 Sep; 39(3):185-201. PubMed ID: 11020134
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill.
Hashimoto S; Honda M; Yamaguchi M; Sekimoto M; Tanaka Y
ASAIO J; 1997; 43(1):84-8. PubMed ID: 9116359
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
Rodloff AC; Laubenthal HJ; Bastian A; Bestehorn K; Büchele G; Gaus W
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Apr; 31(3):172-80. PubMed ID: 8672620
[TBL] [Abstract][Full Text] [Related]
16. The newer cephalosporins. Aztreonam and imipenem.
Ennis DM; Cobbs CG
Infect Dis Clin North Am; 1995 Sep; 9(3):687-713. PubMed ID: 7490439
[TBL] [Abstract][Full Text] [Related]
17. Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient.
Boucher BA
Am J Surg; 2000 Feb; 179(2A Suppl):45S-50S. PubMed ID: 10802265
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of aztreonam and imipenem in critically ill patients with pneumonia.
McKindley DS; Boucher BA; Hess MM; Croce MA; Fabian TC
Pharmacotherapy; 1996; 16(5):924-31. PubMed ID: 8888088
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
